Carriers for the delivery of a vaccine against respiratory syncytial virus

M Cranage, G Taylor - Expert Opinion on Biological Therapy, 2005 - Taylor & Francis
Respiratory syncytial virus (RSV) is a major cause of bronchiolitis and pneumonia in young
children and the elderly. Despite its clinical importance, there is no licensed vaccine …

Active and passive immunisation against respiratory syncytial virus

M Zambon - Reviews in medical virology, 1999 - Wiley Online Library
RSV is a major cause of respiratory illness in infants under 2 years of age. Evidence is
accumulating that it is also underestimated as a cause of respiratory infection in adults, the …

Vaccines against human respiratory syncytial virus in clinical trials, where are we now?

I Rossey, X Saelens - Expert review of vaccines, 2019 - Taylor & Francis
Introduction: Human respiratory syncytial virus (RSV) is a major health threat both for the
very young and the elderly. With yearly 3.2 million hospital admissions and approximately …

Respiratory syncytial virus vaccine: Is it coming?

V Sales, EEL Wang - Paediatrics & Child Health, 2003 - academic.oup.com
Respiratory syncytial virus (RSV) is recognized as an important cause of childhood morbidity
and mortality. Vaccine development has been challenging in young infants and has required …

Current concepts and progress in RSV vaccine development

AK Guvenel, C Chiu, PJM Openshaw - Expert review of vaccines, 2014 - Taylor & Francis
Respiratory syncytial virus (RSV) disease is an important cause of morbidity and mortality in
children and debilitated adults and remains one of the major global unmet challenges for …

Advances in and the potential of vaccines for respiratory syncytial virus

PA Jorquera, KE Oakley, RA Tripp - Expert review of respiratory …, 2013 - Taylor & Francis
Respiratory syncytial virus (RSV) is the leading cause of serious lower respiratory track
illness causing bronchiolitis and some mortality in infants and the elderly. Despite decades …

Respiratory syncytial virus vaccine development

JL Hurwitz - Expert review of vaccines, 2011 - Taylor & Francis
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract viral disease
in infants and young children. Presently, there are no explicit recommendations for RSV …

[图书][B] Challenges and opportunities for respiratory syncytial virus vaccines

LJ Anderson, BS Graham - 2013 - Springer
Respiratory syncytial virus (RSV) was first isolated from chimpanzees in 1955, and shortly
thereafter from young children, and recognized as an important cause of serious lower …

Current state and challenges in developing respiratory syncytial virus vaccines

C Biagi, A Dondi, S Scarpini, A Rocca, S Vandini… - Vaccines, 2020 - mdpi.com
Respiratory syncytial virus (RSV) is the main cause of acute respiratory tract infections in
infants and it also induces significant disease in the elderly. The clinical course may be …

The future of respiratory syncytial virus vaccine development

FP Polack, RA Karron - The Pediatric infectious disease journal, 2004 - journals.lww.com
Background. Respiratory syncytial virus (RSV) is the leading cause of viral lower respiratory
tract illness in infants and children and is an important cause of lower respiratory tract illness …